• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Allopurinol

Allopurinol

Product ID A4445
Cas No. 315-30-0
Purity ≥98%
Product Unit SizeCostQuantityStock
5 g $39.00 In stock
10 g $46.00 In stock
50 g $65.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Allopurinol is a purine analog that mimics hypoxanthine, inhibiting xanthine oxidase; it is clinically used to treat diseases of hyperuricemia, such as gout. Allopurinol exhibits anti-inflammatory, nephroprotective, antinociceptive, antioxidative, anti-fibrotic, and cardioprotective activities. In animal models of renal ischemia, allopurinol decreases production of inflammatory cytokines. In other animal models, allopurinol decreases oxidative stress, suppresses atrial fibrosis, and prevents atrial fibrillation. Additionally, this compound also decreases nociception in animal models of thermal and chemical pain, likely due to increasing levels of hypoxanthine and xanthine, which are metabolized downstream to form adenosine.

Product Info

Cas No.

315-30-0

Purity

≥98%

Formula

C5H4N4O

Formula Wt.

136.11

Chemical Name

1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

IUPAC Name

1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one

Synonym

Adenock, Apurol, Allozym, Apurin, Bloxanth, Embarin, Gichtex, Ketanrift, Lysuron, Urosin, Zyloric

Melting Point

>350°C

Solubility

20mg/mL in DMSO 0.5mg/mL in MeOH 0.30 mg/mL in EtOH 0.48 mg/mL in water

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

A4445 MSDS PDF

Info Sheet

A4445 Info Sheet PDF

References

Prieto-Moure B, Carabén-Redaño A, Aliena-Valero A, et al. Allopurinol in renal ischemia. J Invest Surg. 2014 Oct;27(5):304-16. PMID: 24914485.

Essawy SS, Elbaz AA. Role of adenosine receptors in the anti-nociceptive effects of allopurinol in mice. Eur Rev Med Pharmacol Sci. 2013 Jul;17(14):1857-63. PMID: 23877847.

Sakabe M, Fujiki A, Sakamoto T, et al. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction. J Cardiovasc Electrophysiol. 2012 Oct;23(10):1130-5. PMID: 22587612.

Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006 Mar;58(1):87-114. PMID: 16507884.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P2994

    Physalaemin

    Amphibian tachykinin neuropeptide.

    ≥95%
  • R2512

    RGD

    Tripeptide, binds cell surface integrins.

    ≥95%
  • T3202

    Tianeptine

    μOR and δOR agonist, D2/D3 DA potentiator.

    ≥98%
  • R1777

    9-cis-Retinoic Acid

    Vitamin A derivative; RAR and RXR agonist.

    ≥99%
  • T1852

    Tenovin-1

    SIRT1/2 inhibitor, indirect p53 activator.

    ≥98%
  • A0917

    1′-S-1′-Acetoxychavicol Acetate

    TRPA1 agonist, xanthine oxidase inhibitor.

    ≥98%
  • S6131

    N,N-Dimethyl-Sphingosine

    PP2A activator, Sphk1 and PKC inhibitor.

    ≥98%
  • T3324

    Tigecycline

    Glycylcycline; protein synthesis inhibitor.

    ≥98%
  • R3374

    Risedronic Acid

    Bisphosphonate; inhibits transfer of farnesyl p...

    ≥97%
  • O938565

    6-Oxodocetaxel

    Docetaxel impurity

    ≥98%
  • K2412

    KGDS

    Synthetic peptide, fibrinogen derivative; glyco...

    ≥95%
  • U6854

    Urocortin, human

    Endogenous peptide hormone, involved in feeding...

    ≥98%
  • L302690

    LHRH Acetate Salt

    Endogenous peptide hormone, involved in secreti...

    ≥95%
  • S041001

    SB-202190

    Highly selective inhibitor

    ≥99%
  • S584778

    Sotorasib

    KRAS inhibitor

    ≥99%
  • U5232

    Uniconazole

    Triazole; gibberellin inhibitor, potential 14-Î...

    ≥98%
  • S5746

    Solanesol

    All-trans nonaprenol isoprenoid, found in Solan...

    TLC≥95%
  • B465806

    BLU-667

    RET inhibitor.

    ≥98%
  • S1843

    L-Selectin

    Endogenous adhesion molecule, binds PKC, calmod...

    ≥95%
  • A4931

    3-Aminobenzamide

    PARP inhibitor.

    ≥97%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only